El Harith Abdallah, Abass Elfadil, Martinkovic Franjo, Mansour Durria, Osman Hussam Ali
Department of Biomedical Research, School of Pharmacy, Ahfad University for Women, Omdurman, Sudan.
Department of Clinical Laboratory Science, College of Applied Medical Sciences, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Access Microbiol. 2025 Jan 6;7(1). doi: 10.1099/acmi.0.000890.v4. eCollection 2025.
Proper identification and management of post-kala-azar dermal leishmaniasis (PKDL) and canine leishmaniasis (CanL) cases are among the prerequisites to the effective control of visceral leishmaniasis worldwide. Unlike PKDL, CanL still awaits effective improvement because of its cryptic nature, absence of parasites in lesions or lymph nodes and not complete sensitivity of some diagnostic tools in use. Because of the need for certain skills and equipment, both the liquid direct agglutination test and freeze-dried direct agglutination test (FD-DAT) versions are, in comparison with the indirect immunofluorescence antibody test (IFAT) or enzyme-linked immunosorbent assay (ELISA), practical and feasible diagnostic alternatives. Validate the performance of an improved FD-DAT to suit routine and large-scale applications in CanL endemic areas. Introducing citrate-saline formaldehyde (CSF) as an anti-clumping agent to replace normal saline for antigen reconstitution and drastically, however, eligibly lower the concentration of promastigotes (1.4×10) in comparison with the original FD-DAT reference (>5×10 ml). To ensure optimal safety, -mercaptoethanol was replaced by urea or SDS as a serum-reducing agent. By improving the procedure for reconstitution of FD-DAT antigen with CSF, a 150% reduction in the test application cost was achieved. Expired test batches (±4 years earlier) were successfully revitalized to full validity. As compared to the 48 h shelf-life time for the original, an FD-DAT batch reconstituted here with CSF maintained stability for ±12 months. The highly concordant results with IFAT and ELISA (one-way ANOVA test, =0.142, homogeneity of variances =0.009) as routine CanL diagnostics further motivate the application of the improved FD-DAT for the detection of the disease in endemic areas.
正确识别和管理黑热病后皮肤利什曼病(PKDL)和犬利什曼病(CanL)病例是在全球有效控制内脏利什曼病的先决条件之一。与PKDL不同,CanL由于其隐匿性、病变或淋巴结中无寄生虫以及一些现有诊断工具的敏感性不完全等原因,仍有待有效改善。由于需要特定的技能和设备,与间接免疫荧光抗体试验(IFAT)或酶联免疫吸附测定(ELISA)相比,液体直接凝集试验和冻干直接凝集试验(FD - DAT)版本都是实用且可行的诊断选择。验证改进后的FD - DAT在CanL流行地区用于常规和大规模应用的性能。引入柠檬酸盐 - 盐水 - 甲醛(CSF)作为抗凝聚剂来替代生理盐水进行抗原重构,然而,与原始FD - DAT参考值(>5×10/ml)相比,可大幅且适当地降低前鞭毛体浓度(1.4×10)。为确保最佳安全性,用尿素或十二烷基硫酸钠替代β - 巯基乙醇作为血清还原剂。通过改进用CSF重构FD - DAT抗原的程序,试验应用成本降低了150%。过期的试验批次(提前约4年)成功恢复到完全有效状态。与原始产品48小时的保质期相比,此处用CSF重构的FD - DAT批次保持了约12个月的稳定性。作为常规CanL诊断方法,与IFAT和ELISA的高度一致结果(单向方差分析检验,F = 0.142,方差齐性 = 0.009)进一步推动了改进后的FD - DAT在流行地区疾病检测中的应用。